Study indicates lipolytic consequences with minimal effect on insulin sensitivity. The peptide has undergone human trials with commonly favorable safety profiles, however FDA acceptance for clinical use stays absent. Domestic US distributors typically resell peptides made abroad but operate warehouses, customer support, and shipping from America